...
首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Evaluation of chitosan–anionic polymers based tablets for extended-release of highly water-soluble drugs
【24h】

Evaluation of chitosan–anionic polymers based tablets for extended-release of highly water-soluble drugs

机译:壳聚糖-阴离子聚合物基片剂对高水溶性药物缓释的评价

获取原文
           

摘要

Abstract The objective of this study is to develop chitosan–anionic polymers based extended-release tablets and test the feasibility of using this system for the sustained release of highly water-soluble drugs with high drug loading. Here, the combination of sodium valproate (VPS) and valproic acid (VPA) were chosen as the model drugs. Anionic polymers studied include xanthan gum (XG), carrageenan (CG), sodium carboxymethyl cellulose (CMC-Na) and sodium alginate (SA). The tablets were prepared by wet granulation method. In?vitro drug release was carried out under simulated gastrointestinal condition. Drug release mechanism was studied. Compared with single polymers, chitosan–anionic polymers based system caused a further slowdown of drug release rate. Among them, CS–xanthan gum matrix system exhibited the best extended-release behavior and could extend drug release for up to 24?h. Differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR) studies demonstrated that polyelectrolyte complexes (PECs) were formed on the tablet surface, which played an important role on retarding erosion and swelling of the matrix in the later stage. In conclusion, this study demonstrated that it is possible to develop highly water-soluble drugs loaded extended-release tablets using chitosan–anionic polymers based system.
机译:摘要这项研究的目的是开发基于壳聚糖-阴离子聚合物的缓释片剂,并测试将该系统用于高载药量的高水溶性药物的持续释放的可行性。在这里,选择丙戊酸钠(VPS)和丙戊酸(VPA)的组合作为模型药物。研究的阴离子聚合物包括黄原胶(XG),角叉菜胶(CG),羧甲基纤维素钠(CMC-Na)和藻酸钠(SA)。通过湿法制粒制备片剂。在模拟胃肠道条件下进行体外药物释放。研究了药物释放机理。与单一聚合物相比,基于壳聚糖-阴离子聚合物的体系进一步降低了药物释放速率。其中,CS-黄原胶基质系统表现出最佳的缓释性能,并且可以延长药物释放长达24小时。差示扫描量热法(DSC)和傅里叶变换红外光谱(FTIR)研究表明,在片剂表面形成了聚电解质复合物(PEC),在后期抑制基质侵蚀和膨胀方面起着重要作用。总之,这项研究表明,使用基于壳聚糖-阴离子聚合物的系统,可以开发出水溶性高的缓释片剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号